James Mosley, MD
Family Medicine · Nashville, TNNPI 1417948076
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 21.8% of the total. Reporting peaked in 2022 at $51 and has fallen 54.3% since, to $23 in 2025. That places this record below the midpoint for family medicine clinicians in TN, where the typical reported total is $470.
Across 9 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$33
- Eisai Inc.$27
- Blueprint Medicines Corporation$23
- Takeda Pharmaceuticals U.S.A., Inc.$21
- Daiichi Sankyo Inc.$16
- Myriad Genetic Laboratories, Inc.$16
- plus $14 from 1 others
Across 5 payments — averaging $17,031 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Seagen Inc.$85K
What the payments were for
- Food & beverage$151100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 2 | $33 |
| Eisai Inc. | 2 | $27 |
| Blueprint Medicines Corporation | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Myriad Genetic Laboratories, Inc. | 1 | $16 |
| Coherus Oncology, Inc. | 1 | $14 |
How this compares
$151 in reported general payments places this provider in the 30th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $1,119 |
| Doxycycline Hyclate | 97 | $832 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 46 | $453 |
| Cefdinir | 23 | $356 |
| MoxifloxacinMoxifloxacin Hcl | 13 | $284 |
| Prednisone | 142 | $240 |
| Diclofenac Sodium | 15 | $180 |
| Amoxicillin | 45 | $174 |
| Mupirocin | 22 | $169 |
| Nystatin | 12 | $138 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $125 |
| Cephalexin | 26 | $111 |
| Ondansetron OdtOndansetron | 13 | $69 |
| Azithromycin | 14 | $35 |
| PaxlovidNirmatrelvir/Ritonavir | 19 | $0 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Nashville
- Keren HolmesNashville$58K
- Burton SandersNashville$19K
- Julia GomezNashville$18K
- Christopher HoffmanNashville$17K
- John AdewumiNashville$15K
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.